Ethyl 2-(1-Benzylpiperidin-4-ylidene)acetate, 97.0%, 10g

6-Chloro-4-hydroxyquinolin-2(1H)-one, 95.0%, 5g

3-Bromo-5-trifluoromethylthioanisole, 98%, 10g

ETHYL 4,6-DIMETHYLNICOTINATE, 95%, 250mg

n-Dodecane, min. 95%, for synthesis, 500 ml, glass packaging

Perfluoro-2,5,8-trioxadodecyl bromide, 98.0%, 1g

7-Bromoquinoline, 97.0%, 25g

tert-butyl [(3Z)-3-amino-3-(hydroxyimino)propyl]carbamate, 95.0%, 5g

2-(2-Methoxy-4-methylphenoxy)acetic acid, 95+%, 1g

6-(Piperidin-1-yl)pyridin-3-amine, 95.0%, 1g

(S)-Methyl 2-hydroxy-3-phenylpropanoate, 95.0%, 25g

4,4'-(Phenylphosphoryl)dibenzoic acid, 95%, 10g

2-Cyano-3-(4-fluorophenyl)propionic acid, 97.0%, 250mg